Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey J Rowe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Australasian Journal of Dermatology|May 27, 2015
Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?Casey J Rowe, Kiarash Khosrotehrani
The Australasian Journal of Dermatology|March 6, 2014
Warfarin-induced erythrodermaCasey J Rowe, Ivan Robertson, Daniel James, et al.
International Journal of Cancer|October 22, 2014
PARP1 polymorphisms play opposing roles in melanoma occurrence and survivalMatthew H Law, Casey J Rowe, Grant W Montgomery, et al.
International Journal of Cancer|March 19, 2016
Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanomaCasey J Rowe, Fiona Tang, Maria Celia B Hughes, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Australasian Journal of Dermatology|May 27, 2015
Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?Casey J Rowe, Kiarash Khosrotehrani
The Australasian Journal of Dermatology|March 6, 2014
Warfarin-induced erythrodermaCasey J Rowe, Ivan Robertson, Daniel James, et al.
International Journal of Cancer|October 22, 2014
PARP1 polymorphisms play opposing roles in melanoma occurrence and survivalMatthew H Law, Casey J Rowe, Grant W Montgomery, et al.
International Journal of Cancer|March 19, 2016
Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanomaCasey J Rowe, Fiona Tang, Maria Celia B Hughes, et al.
Pageof 1